12/05/2024 | Press release | Archived content
Toyama and Kawasaki, Japan, December 5, 2024
Nichi-Iko Pharmaceutical Co., Ltd. and Fujitsu Limited today announced the ongoing progress of a joint field trial. The initiative aims to aid the detection of omissions in sterile room entry and exit procedures and enhance the training of manufacturing engineers at Nichi-Iko's pharmaceutical manufacturing facility. It leverages Fujitsu's behavioral analysis AI service, "Fujitsu Kozuchi for Vision", and Broadleaf Co., Ltd.'s productivity and business optimization software, "OTRS" and "OTRS+AI."
1. Trial period:
November 19, 2024 - December 20, 2024
2. Location:
Nichi-Iko Pharmaceutical Co., Ltd. Gifu Plant (Takayama City, Gifu Prefecture, Japan)
3. Details:
Based on the results of this joint field trial, both companies will work towards the full-scale introduction of Fujitsu Kozuchi for Vision, OTRS, and OTRS+AI at the Nichi-Iko Gifu plant by March 2025.
Nichi-Iko will leverage the knowledge gained from this joint field trial to establish the Nichi-Iko Gifu plant as a model smart factory. By replicating this model across all its plants in Japan, Nichi-Iko aims to accelerate DX across its manufacturing and contribute to the stable supply of pharmaceuticals.
Fujitsu will continue to support Nichi-Iko's smart factory initiatives and DX efforts in pharmaceutical manufacturing.
Fujitsu's purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.
Nichi-Iko Pharmaceutical Co., Ltd.
Tel : (+81)076-442-7026
Fujitsu Limited
Public and Investor Relations Division
Inquiries
All company or product names mentioned herein are trademarks or registered trademarks of their respective owners. Information provided in this press release is accurate at time of publication and is subject to change without advance notice.